• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vera Therapeutics, Inc. - Class A Common Stock (NQ:VERA)

    45.77 +0.94 (+2.10%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,285,269
    Open 44.93
    Bid (Size) 45.45 (100)
    Ask (Size) 47.22 (200)
    Prev. Close 44.83
    Today's Range 44.67 - 46.31
    52wk Range 18.53 - 56.05
    Shares Outstanding 44,261,109
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Vera Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    -5.9%
    -5.9%
    1 Month
    -14.9%
    -14.9%
    3 Month
    +52.9%
    +52.9%
    6 Month
    +102.3%
    +102.3%
    1 Year
    +35.8%
    +35.8%

    More News

    Read More
    News headline image
    Why Vera Therapeutics Stock Zoomed Higher Today ↗
    Via The Motley Fool
    News headline image
    Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Why Vera Therapeutics Stock Rocked the Market on Tuesday ↗
    Via The Motley Fool
    News headline image
    Why Vera Therapeutics Stock Crushed it Today ↗
    Via The Motley Fool
    News headline image
    Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
    Via Chartmill
    News headline image
    Vera Therapeutics to Participate at Upcoming Investor Conferences
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
    Via Benzinga
    News headline image
    VERA THERAPEUTICS INC (NASDAQ:VERA) Reports Q3 2025 Earnings, Misses EPS Estimates Amid Key Clinical Progress ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase ↗
    Via The Motley Fool
    News headline image
    Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares ↗
    Via The Motley Fool
    News headline image
    Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025
    From Vera Therapeutics
    Via GlobeNewswire
    News headline image
    Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market ↗
    Via Benzinga
    News headline image
    This Celestica Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
    Via Benzinga

    Frequently Asked Questions

    Is Vera Therapeutics, Inc. - Class A Common Stock publicly traded?
    Yes, Vera Therapeutics, Inc. - Class A Common Stock is publicly traded.
    What exchange does Vera Therapeutics, Inc. - Class A Common Stock trade on?
    Vera Therapeutics, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Vera Therapeutics, Inc. - Class A Common Stock?
    The ticker symbol for Vera Therapeutics, Inc. - Class A Common Stock is VERA on the Nasdaq Stock Market
    What is the current price of Vera Therapeutics, Inc. - Class A Common Stock?
    The current price of Vera Therapeutics, Inc. - Class A Common Stock is 45.77
    When was Vera Therapeutics, Inc. - Class A Common Stock last traded?
    The last trade of Vera Therapeutics, Inc. - Class A Common Stock was at 01/21/26 04:00 PM ET
    What is the market capitalization of Vera Therapeutics, Inc. - Class A Common Stock?
    The market capitalization of Vera Therapeutics, Inc. - Class A Common Stock is 2.03B
    How many shares of Vera Therapeutics, Inc. - Class A Common Stock are outstanding?
    Vera Therapeutics, Inc. - Class A Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.